GlaxoSmithKline PLCGSK:LSE

1,412.5
14.50 / 1.04%
3.63m
14.06%
0.5063
Latest price in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Oct 31 2014 14:43 GMT.

Consensus recommendation

As of Oct 25, 2014, the consensus forecast amongst 56 polled investment analysts covering GlaxoSmithKline plc advises investors to hold their position in the company. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Feb 21, 2013. The previous consensus forecast advised that GlaxoSmithKline plc would outperform the market.

Previous recommendations
Last year3 months ago2 months ago4 weeks agoLatest
Mouseover chart recommendation details.
Latest recommendation
Buy9
Outperform10
Hold22
Underperform4
Sell4
No opinion0

Share price forecast

The 22 analysts offering 12 month price targets for GlaxoSmithKline plc have a median target of 1,524, with a high estimate of 1,758 and a low estimate of 1,250. The median estimate represents a 9.01% increase from the last price of 1,398. View Full Financials

High+24.5 %1,758
Med+7.9 %1,524
Low-11.5 %1,250

Dividends

In 2013, GlaxoSmithKline PLC reported a dividend of 0.78 GBP, which represents a 5.41% increase over last year. The 14 analysts covering the company expect dividends of 0.80 GBP for the upcoming fiscal year, an increase of 2.31%. View Full Financials

Div growth (TTM)+5.41%
  • Mouseover chart for details.
  • Dividend forecast
  • Quarter 1
  • Quarter 2
  • Quarter 3
  • Quarter 4

Earnings history & estimates

On Oct 22, 2014, GlaxoSmithKline plc reported 3rd quarter 2014 earnings of 0.279 per share. This result exceeded the 0.24 consensus of the 9 analysts covering the company and under-performed last year's 3rd quarter results by 3.46%.
The next earnings announcement is expected on Feb 04, 2015. View Full Interim Financials

Average growth rate+2.88%

GlaxoSmithKline plc reported annual 2013 earnings of 1.12 per share on Feb 05, 2014.
The next earnings announcement from GlaxoSmithKline plc is expected the week of Feb 04, 2015. View Full Annual Financials

Average growth rate-1.42%
  • Mouseover chart for details.
  • Reported results
  • Forecasts
  • Pos/Neg restatement

Revenue

GlaxoSmithKline plc had 3rd quarter 2014 revenues of 5.65bn. This missed the 5.75bn consensus estimate of the 9 analysts following the company. This was 1.53% above the prior year's 3rd quarter results. View Full Interim Financials

Average growth rate-3.01%

GlaxoSmithKline plc had revenues for the full year 2013 of 26.51bn. This was 0.28% above the prior year's results. View Full Annual Financials

Average growth rate-1.67%
  • Mouseover chart for details.
  • Reported results
  • Forecasts
  • Pos/Neg restatement
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.